Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating activities
Net increase (decrease) in net assets resulting from operations		$ (3,027,189)			$ 11,617,485
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	$ (21,027)	0		$ 0	1,811	$ 0
Change in net unrealized (appreciation) depreciation of investments		3,053,146			(2,837,191)
Net amortization of investment discounts and premiums		(3,965)			(1,363,492)
Interest and dividend income paid in kind		0			(279,515)
Amortization of deferred debt issuance costs		13,960			94,278
Changes in assets and liabilities:
Purchase of investments		(107,747,598)			(68,123,549)
Proceeds from disposition of investments		23,431			31,086,458
Decrease (increase) in interest, dividends and fees receivable		(154,675)			(585,204)
Decrease (increase) in receivable for investments sold		(23,431)			(1,099,100)
Decrease (increase) in prepaid expenses and other assets		(82,859)			39,071
Increase (decrease) in payable for investments purchased		88,897,983			(6,983,566)
Increase (decrease) in interest and debt related payables		0			270,050
Increase (decrease) in reimbursements due to the Investment Adviser		11,050			60,109
Increase (decrease) in accrued expenses and other liabilities		234,831			720,952
Net cash provided by (used in) operating activities		(18,805,316)			(37,381,403)
Financing activities
Proceeds from common shares sold		50,000,000			26,985,992
Contribution received in advance		0			4,574,394
Draws on credit facilities		0			40,000,000
Repayments of credit facility draws		0			(36,000,000)
Payments of debt issuance costs		(1,888,726)			(19,253)
Dividends paid in cash to shareholders		0			(459,654)
Net cash provided by (used in) financing activities		48,111,274			35,081,479
Net increase (decrease) in cash and cash equivalents (including restricted cash)		29,305,958			(2,299,924)
Cash and cash equivalents (including restricted cash) at beginning of period		0			17,633,729
Cash and cash equivalents (including restricted cash) at end of period	$ 15,333,805	$ 29,305,958	$ 29,305,958	$ 29,305,958	15,333,805	$ 29,305,958
Supplemental cash flow information
Interest payments			0		3,020,273
Excise tax payments			0		18,395
Distribution payable			0		1,379,449
Reinvestment of dividends during the period			$ 0		$ 6,709,771